Production of the Chinese Sinopharm Covid-19 vaccine is going on under safe conditions, a senior official of Hungary’s National Institute of Pharmacy and Nutrition (OGYEI) said on Monday morning.
The vaccine is being produced in a factory using highly modern technology, Ferenc Lukács, the head of the authority’s inspection department who has reviewed production of the Sinopharm Covid-19 vaccine in Beijing, told public news broadcaster M1 from the site.
It requires additional inspection to verify the degree of effectiveness of the drug, he said.
Gergely Gulyás, who heads the Prime Minister’s Office, said at a press briefing on Thursday that Hungary had “practically reached an agreement” on a delivery of the Sinopharm vaccine. He added that the first shipment could be as large as one million doses, pending approval by Hungarian medicines authorities. On Friday, Prime Minister Orbán said that hopefully the authority would provide a clear response within the next few days. Meanwhile, leftist Opposition Democratic Coalition has launched a petition against allowing inoculation in Hungary with any Chinese Covid-19 vaccine that has not been approved by the European Medicines Agency (EMA).
Featured photo illustration by MTI/AP/Xinhua News Agency/Zhang Yuwei